PPT-First-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials
Author : willow | Published Date : 2023-07-07
Saito M McGready R Tinto H Rouamba T Mosha D Rulisa S Kariuki S Desai M Manyando C Njunju EM Sevene E Vala A Augusto O Clerk C Were E Mrema S Kisinza W Byamugisha
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "First-trimester treatment with artemisin..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
First-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: Transcript
Saito M McGready R Tinto H Rouamba T Mosha D Rulisa S Kariuki S Desai M Manyando C Njunju EM Sevene E Vala A Augusto O Clerk C Were E Mrema S Kisinza W Byamugisha J Kagawa M Singlovic J Yore M van Eijk A Mehta U Stergachis A Hill J Stepniewska K Gomes M Guerin P Nosten F ter Kuile FO Dellicour S. ISBN 978 92 4 150532 1 REGIONAL FRAORK FORCT2013-2015 Emergency response to artemisinin resistance in the Greater Mekong subregion: regional framework for action 2013-2015.1.Antimalarials thera IN . THE FIRST TRIMESTER . ON . FETAL NUCHAL TRANSLUCENCY. . Ziya. . Kalem,MD. Gurgan. Clinic IVF and Women Health Center. Progesterone . could might cause abnormal blood flow patterns and, subsequently, increased . of artemisinin derivatives which are rapidly acting schizonticidal drugs, the mortality is expected to decline. In an openrandomised study, arteether, the ethyl derivative of artemisinin was used to c Targeted and purposeful alteration of metabolic pathways found in an organism in order to better understand and use cellular pathways : . - To increase the production rate of the existing products. Labaran. , CPIPP ABU Zaria . MALARIA: THE PROBLEM. Every year: worldwide. > 200 million clinical cases. > 2 million deaths from malaria mainly in Africa. DRUGS ARE FAILING . Pilot implementation of RTS,S/AS01 vaccine. Targeted and purposeful alteration of metabolic pathways found in an organism in order to better understand and use cellular pathways for the production of valuable products. Practice of optimizing genetic and regulatory processes within cells to increase the cells' production of a substance. . Non-Toxic Targeted Cancer Therapies. Jeffrey Dach MD. 7450 Griffin Road Suite 190. Davie, FL 33021. 954-792-4663. www.jeffreydachmd.com. Slides . Available At. : http://www.jeffreydachmd.com. Most of the Drugs . (N11108299). TUGAS KULTUR JARINGAN TUMBUHAN. Berasal dari daerah subtropis seperti Cina, Irian jaya dan amerika.. Termasuk herba yang hidup di dataran menengah sampai pegunungan di atas permukaan laut (800-2000 m). Nguyen Tran. Center . for Infectious Disease . Dynamics (CIDD), . Dept. of Biology, Penn . State University. BMGF Malaria Modeling Consortium. 6th Annual Disease Modeling Symposium. April 16. th. . What is synthetic biology?. The synthetic yeast project. The Scramble system. Network analysis to understand cell dynamics. Synthetic Biology?. What is. Robert H. Newman. North Carolina A&T State University. Mitchell A. Avery. , . Wesley K. M. Chong. , . and . Clive Jennings-White, . J. . . Am. . Chem. . Soc. . . 1992. , . 114. ,914-919. Songnan. Zhang. 2/26/2013. 2013-2-26. 1. Mitchell A. . Avery. 1975, B.S. . 2 – 4 October 2019, Geneva, Switzerland Background document for Session 3 This document was prepared as a pre - read for the meeting of the Malaria Policy Advisory Committee and is not an official d UNCLASSIFIED. Dr. Ben Andagalu. Co-Director,. Malaria Drug Resistance Laboratory,. US Army Medical Research Directorate-Africa |KEMRI. ben.andagalu@usamru-k.org. Disclaimer. . Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70–25. Rakita RM, Malhotra U. Widespread Availability of Artemisinin Monotherapy in the United States. Emerg Infect Dis. 2011;17(5):954-955. https://doi.org/10.3201/eid1705.101532.
Download Document
Here is the link to download the presentation.
"First-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents